Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Mathieu Beauregard

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Nuclear Medicine and Biology|March 27, 2007
Effective specific activities determined by scintillation proximity counting for production runs of [(18)F]FES and 4F-M[(18)F]FESJean-Mathieu Beauregard, Etienne Croteau, Naseem Ahmed, et al.
Biomedicines|November 27, 2021
Optimizing the Schedule of PARP Inhibitors in Combination with <sup>177</sup>Lu-DOTATATE: A Dosimetry RationaleAndreas Hallqvist, Johanna Svensson, Linn Hagmarker, et al.
EJNMMI Physics|February 16, 2020
Comprehensive SPECT/CT system characterization and calibration for <sup>177</sup>Lu quantitative SPECT (QSPECT) with dead-time correctionAndrea Frezza, Corentin Desport, Carlos Uribe, et al.
Medical Physics|December 11, 2013
An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imagingPrice A Jackson, Jean-Mathieu Beauregard, Michael S Hofman, et al.
Oncotarget|June 7, 2018
Potentiation of <sup>177</sup>Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitorNupur K Purohit, Rashmi G Shah, Samuel Adant, et al.
Cancers|January 13, 2021
Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of <sup>177</sup>Lu-DOTA-Octreotate in Neuroendocrine Tumor CellsRashmi G Shah, Marine A Merlin, Samuel Adant, et al.
EJNMMI Physics|January 8, 2017
Accuracy of <sup>177</sup>Lu activity quantification in SPECT imaging: a phantom studyCarlos F Uribe, Pedro L Esquinas, Jesse Tanguay, et al.
EJNMMI Physics|October 16, 2018
Accuracy and reproducibility of simplified QSPECT dosimetry for personalized <sup>177</sup>Lu-octreotate PRRTMichela Del Prete, Frédéric Arsenault, Nassim Saighi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 19, 2013
Rapid blood clearance and lack of long-term renal toxicity of 177Lu-DOTATATE enables shortening of renoprotective amino acid infusionRaghava Kashyap, Price Jackson, Michael S Hofman, et al.
EJNMMI Physics|June 4, 2017
A CZT-based blood counter for quantitative molecular imagingRomain Espagnet, Andrea Frezza, Jean-Pierre Martin, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Nuclear Medicine and Biology|March 27, 2007
Effective specific activities determined by scintillation proximity counting for production runs of [(18)F]FES and 4F-M[(18)F]FESJean-Mathieu Beauregard, Etienne Croteau, Naseem Ahmed, et al.
Biomedicines|November 27, 2021
Optimizing the Schedule of PARP Inhibitors in Combination with <sup>177</sup>Lu-DOTATATE: A Dosimetry RationaleAndreas Hallqvist, Johanna Svensson, Linn Hagmarker, et al.
EJNMMI Physics|February 16, 2020
Comprehensive SPECT/CT system characterization and calibration for <sup>177</sup>Lu quantitative SPECT (QSPECT) with dead-time correctionAndrea Frezza, Corentin Desport, Carlos Uribe, et al.
Medical Physics|December 11, 2013
An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imagingPrice A Jackson, Jean-Mathieu Beauregard, Michael S Hofman, et al.
Oncotarget|June 7, 2018
Potentiation of <sup>177</sup>Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitorNupur K Purohit, Rashmi G Shah, Samuel Adant, et al.
Cancers|January 13, 2021
Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of <sup>177</sup>Lu-DOTA-Octreotate in Neuroendocrine Tumor CellsRashmi G Shah, Marine A Merlin, Samuel Adant, et al.
EJNMMI Physics|January 8, 2017
Accuracy of <sup>177</sup>Lu activity quantification in SPECT imaging: a phantom studyCarlos F Uribe, Pedro L Esquinas, Jesse Tanguay, et al.
EJNMMI Physics|October 16, 2018
Accuracy and reproducibility of simplified QSPECT dosimetry for personalized <sup>177</sup>Lu-octreotate PRRTMichela Del Prete, Frédéric Arsenault, Nassim Saighi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 19, 2013
Rapid blood clearance and lack of long-term renal toxicity of 177Lu-DOTATATE enables shortening of renoprotective amino acid infusionRaghava Kashyap, Price Jackson, Michael S Hofman, et al.
EJNMMI Physics|June 4, 2017
A CZT-based blood counter for quantitative molecular imagingRomain Espagnet, Andrea Frezza, Jean-Pierre Martin, et al.
Pageof 7